NCT05698212 is a Phase 2 clinical trial of MetriDx in Endometriosis, sponsored by Hera Biotech, Inc..

Who is sponsoring NCT05698212?

NCT05698212 is sponsored by Hera Biotech, Inc..

What drugs are being tested in NCT05698212?

Interventions in NCT05698212: MetriDx.

What condition does NCT05698212 study?

NCT05698212 studies Endometriosis, Diagnosis.

Is NCT05698212 still recruiting?

NCT05698212 is currently recruiting now. Last updated 26 January 2023.

Last reviewed 2023-01-26 · How we verify

NCT05698212

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

Recruiting now Phase 2 Last updated 26 January 2023

What this trial tests

Phase 2 trial testing MetriDx in Endometriosis in 75 participants. Currently enrolling.

Timeline

14 September 2022

Primary endpoint
25 March 2023

10 April 2023

Quick facts

Lead sponsor	Hera Biotech, Inc.
Phase	Phase 2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	75
Start date	14 September 2022
Primary completion	25 March 2023
Estimated completion	10 April 2023
Sites	3 locations across United States

Drugs / interventions tested

MetriDx

Conditions studied

Endometriosis — all drugs for Endometriosis →
Diagnosis — all drugs for Diagnosis →

Sponsor

Hera Biotech, Inc.

Who can join

Adults 18 to 50, female only, with Endometriosis or Diagnosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
NCT07393295 — Efficacy and Tolerability of TENS in Endometriosis-related Pain · NA · recruiting
NCT07134023 — Educational Program for the Multidisciplinary Support of Patients With Endometriosis · NA · recruiting
NCT07240883 — ENDO1000 - A UK-wide Endometriosis Research Project · recruiting
NCT06974773 — Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05698212 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hera Biotech, Inc.
Last refreshed: 26 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05698212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing